14 July 2017
Reporter: Mark Dugdale
Top German court backs compulsory licence
A German court was right to grant a compulsory licence to a patent for a HIV drug, the country’s Federal Court of Justice has ruled.

Germany’s Federal Court of Justice this week upheld a Federal Patent Court decision to grant an injunction ordering the issuance of a compulsory licence to the European patent protecting the underlying compound in Isentress, an anti-viral that treats HIV.

Japanese pharmaceutical company Shionogi owns a family of patents to the raltegravir compound in Isentress.

Merck manufactures and sells Isentress in Europe, but has been unable to agree a worldwide licence with Shionogi for its raltegravir patents, prompting the litigation.

The Federal Court of Justice backed the Federal Patent Court’s decision to force through a compulsory licence, as Merck had made sufficient attempts to negotiate a licence.

There was also significant public interest in keeping access to Isentress open in Germany, where it is the only anti-viral containing raltegravir available and is required to meet the needs of certain patients, including infants, pregnant women, and people who have already been prescribed with Isentress.

Compulsory licences are not granted often, in Europe or globally.

Rwanda and Thailand have issued compulsory licences in the past. In 2012, the Indian government granted a compulsory licence to Natco Pharma to manufacture and distribute Nexavar for 3 percent of the cost of the original drug patented by Bayer, although the licence was eventually revoked.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Stryker’s award increases to $248.7 million
21 July 2017 | Michigan | Reporter: Mark Dugdale
A US district court has increased the sum that medical device maker Zimmer must pay to rival Stryker, following the Supreme Court’s enhanced damages ruling in the litigation
Congressmen Issa and Goodlatte hit out at Judge Gilstrap
20 July 2017 | Washington DC | Reporter: Mark Dugdale
Two members of the House judiciary committee have criticised Judge Rodney Gilstrap for his interpretation of TC Heartland v Kraft Foods, going as far as to suggest that he is putting the needs of the Eastern District of Texas above serving justice
Broad Institute to pool CRISPR patents
20 July 2017 | Massachusetts | Reporter: Barney Dixon
The Broad Institute of MIT and Harvard have entered discussions to create a CRISPR-Cas9 joint patent pool, coordinated by MPEG LA
PatSnap partners with GreyB
20 July 2017 | London | Reporter: Barney Dixon
Intellectual property analytics company PatSnap has entered into a strategic alliance with technology consulting and research firm GreyB
Foley & Lardner boosts IP practice
20 July 2017 | California | Reporter: Barney Dixon
Foley & Lardner has added Duane Mathiowetz and Rick Chang to its San Francisco and Silicon Valley offices
BakerHostetler hires life sciences expert
20 July 2017 | Ohio | Reporter: Barney Dixon
Beverly Lyman has joined BakerHostetler’s intellectual property practice as partner
Eli Lilly maintains patent for erectile dysfunction drug
20 July 2017 | Virginia | Reporter: Mark Dugdale
Eli Lilly has agreed settlements with a group of generics companies to secure the exclusivity of Cialis until September 2018